Literature DB >> 2233719

A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein.

L B Holzman1, R M Marks, V M Dixit.   

Abstract

We have previously described the cloning of a group of novel cellular immediate-early response genes whose expression in human umbilical vein endothelial cells is induced by tumor necrosis factor alpha in the presence of cycloheximide. These genes are likely to participate in mediating the response of the vascular endothelium to proinflammatory cytokines. In this study, we further characterized one of these novel gene products named B61. Sequence analysis of cDNA clones encoding B61 revealed that its protein product has no significant homology to previously described proteins. Southern analysis suggested that B61 is an evolutionarily conserved single-copy gene. B61 is primarily a hydrophilic molecule but contains both a hydrophobic N-terminal and a hydrophobic C-terminal region. The N-terminal region is typical of a signal peptide, which is consistent with the secreted nature of the protein. The mature form of the predicted protein consists of 187 amino acid residues and has a molecular weight of 22,000. Immunoprecipitation of metabolically labeled human umbilical vein endothelial cell preparations revealed that B61 is a 25-kilodalton secreted protein which is markedly induced by tumor necrosis factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2233719      PMCID: PMC361366          DOI: 10.1128/mcb.10.11.5830-5838.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Molecular cloning of gene sequences regulated by platelet-derived growth factor.

Authors:  B H Cochran; A C Reffel; C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Rapid similarity searches of nucleic acid and protein data banks.

Authors:  W J Wilbur; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

9.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

Authors:  R R Schleef; M P Bevilacqua; M Sawdey; M A Gimbrone; D J Loskutoff
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

10.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.

Authors:  M L Dustin; T A Springer
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  41 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.

Authors:  R Holm; S Knopp; Z Suo; C Tropè; J M Nesland
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

3.  Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis.

Authors:  Atsushi Sasahara; Hidetoshi Kasuya; Hiroyuki Akagawa; Hiroshi Ujiie; Osami Kubo; Toshiyuki Sasaki; Hideaki Onda; Yoshiko Sakamoto; Boris Krischek; Tomokatsu Hori; Ituro Inoue
Journal:  Neurosurg Rev       Date:  2007-06-19       Impact factor: 3.042

Review 4.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

5.  Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells.

Authors:  Lifang Zhu; Waruna Lakmal Dissanayaka; David William Green; Chengfei Zhang
Journal:  Cell Prolif       Date:  2015-02-03       Impact factor: 6.831

Review 6.  Cell-cell signaling via Eph receptors and ephrins.

Authors:  Juha-Pekka Himanen; Nayanendu Saha; Dimitar B Nikolov
Journal:  Curr Opin Cell Biol       Date:  2007-10-24       Impact factor: 8.382

7.  Gene expression profiling in an in vitro model of angiogenesis.

Authors:  J Kahn; F Mehraban; G Ingle; X Xin; J E Bryant; G Vehar; J Schoenfeld; C J Grimaldi; F Peale; A Draksharapu; D A Lewin; M E Gerritsen
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.

Authors:  David Kiewlich; Jianhuan Zhang; Cynthia Gross; Wei Xia; Brent Larsen; Ronald R Cobb; Sandra Biroc; Jian-Ming Gu; Takashi Sato; David R Light; Tara Heitner; Joerg Willuda; David Vogel; Felipe Monteclaro; Andrzej Citkowicz; Steve R Roffler; Deborah A Zajchowski
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

10.  Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  Thromb Res       Date:  2008-09-03       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.